Savant Capital LLC Has $2.05 Million Holdings in DENTSPLY SIRONA Inc. $XRAY

Savant Capital LLC lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 12.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 129,234 shares of the medical instruments supplier’s stock after acquiring an additional 14,271 shares during the quarter. Savant Capital LLC’s holdings in DENTSPLY SIRONA were worth $2,052,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of XRAY. Teacher Retirement System of Texas boosted its stake in shares of DENTSPLY SIRONA by 65.7% during the first quarter. Teacher Retirement System of Texas now owns 32,008 shares of the medical instruments supplier’s stock valued at $478,000 after purchasing an additional 12,696 shares in the last quarter. Principal Financial Group Inc. raised its holdings in DENTSPLY SIRONA by 0.4% in the 1st quarter. Principal Financial Group Inc. now owns 457,397 shares of the medical instruments supplier’s stock valued at $6,834,000 after buying an additional 1,708 shares during the last quarter. Envestnet Asset Management Inc. boosted its position in DENTSPLY SIRONA by 9.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock worth $7,391,000 after buying an additional 40,936 shares during the period. Brown Advisory Inc. bought a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $679,000. Finally, Allworth Financial LP grew its holdings in DENTSPLY SIRONA by 175.8% during the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier’s stock worth $54,000 after acquiring an additional 2,517 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Mizuho set a $13.00 price target on shares of DENTSPLY SIRONA in a research note on Friday. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. UBS Group reduced their price target on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, October 28th. Barrington Research lowered their price objective on DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating for the company in a research report on Monday. Finally, Evercore ISI cut their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus price target of $16.08.

DENTSPLY SIRONA Trading Down 0.2%

NASDAQ XRAY opened at $10.98 on Wednesday. The stock has a market capitalization of $2.19 billion, a P/E ratio of -2.32, a P/E/G ratio of 0.81 and a beta of 1.00. The business has a 50 day simple moving average of $12.86 and a 200 day simple moving average of $14.45. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. DENTSPLY SIRONA Inc. has a one year low of $10.69 and a one year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The business had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.